NCT04370509 2025-11-19
Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery
University of California, San Francisco
Phase 2 Terminated
University of California, San Francisco
Wake Forest University Health Sciences
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
SWOG Cancer Research Network
National Institutes of Health Clinical Center (CC)